4 February 2025
World Cancer Day 2025—United in Every Journey


Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

Biology & Life Sciences

Medicine & Pharmacology

Chemistry & Material Sciences

Public Health & Healthcare

Engineering

Society

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

Biomarkers in Breast Cancer: An Old Story with a New End
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032

Comprehensive Treatment of Rectal Cancer

Mental Health and Nursing Care of Individuals with Cancer and Their Families—2nd Edition

New Advances in Community-Based Approaches to Cancer Prevention Epidemiology

Cancer Immunotherapy and the PD-1/PD-L1 Checkpoint Pathway

Novel, Low Cost Technologies for Cancer Diagnostics and Therapeutics

Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

Pulmonary Fibrosis and Lung Cancer: Pathophysiology and Novel Therapeutic Approaches

 

Back to TopTop